Medical technology company RaySearch Laboratories AB (publ) (STO:RAY-B) announced on Friday the appointment of Nina Grönberg as the new chief financial officer, effective 27 January 2025.
With extensive experience in finance leadership roles at various international publicly listed companies, Nina most recently served as CFO at Team Olivia and held previous CFO positions at Duroc. Additionally, she has contributed to accounting, reporting, and business control at Ratos and Munters.
Nina Grönberg says: "RaySearch is an innovative company and a driving force in the fight against cancer. The finance function has an important role to play in this exciting phase of expansion that RaySearch is currently undergoing."
Hemogenyx Pharmaceuticals schedules Phase i clinical trial for HEMO-CAR-T
SciBase and Kilabs partner to advance skin cancer diagnostics in Italy
Henlius and Organon announce FDA acceptance of BLA for denosumab biosimilar, HLX14
I-Mab announces presentation of Phase 1 dose data for givastomig at SITC 2024
Biond Biologics signs clinical trial collaboration and supply agreement with Merck KGaA
Foresee Pharmaceuticals submits US FDA New Drug Application for three-month version of CAMCEVI
GlycoMimetics to combine with Crescent Biopharma
MilliporeSigma expands ADC manufacturing capacity
Merck and Moderna launch new Phase 3 trial for cancer vaccine
RaySearch Laboratories AB names new CFO
Genprex partners with University of Michigan to explore Reqorsa for lung cancer treatment
Elicera Therapeutics completes patient enrolment for phase I/II trial of cancer therapy ELC-100
Repare Therapeutics reports positive safety and tolerability data from Phase 1 MYTHIC trial